Reimherr, F.W., Wender, P.H. , Ebert, M.H., & Wood, D.R. (1984). Cerebrospinal fluid homovanillic acid and 5-hydroxyindole acetic acid in adults with attention deficit disorder, residual type (ADD, RT). Psychiatry Research11, 71-78.
2.
Reimherr, F.W., Wender, P.H. , Wood, D.R., & Ward, M. (1987). An open trial of 1-tyrosine in the treatment of attention deficit disorder, residual type . American Institute of Psychiatry144, 1071-1073.
3.
Ward, M.F., Wender, P.H. , & Reimherr, F.W. ( 1993). The Wender Utah Rating Scale: An aid in the retrospective diagnosis of attention deficit hyperactivity disorder. American Institute of Psychiatry150, 885-890.
4.
Wender, P.H. (1995). Attention-Deficit Hyperactivity Disorder in adults. New York: Oxford University Press.
5.
Wender, P.H. & Reimherr, F.W. (1990). Bupropion treatment of attention-deficit hyperactivity disorder in adults. American Institute of Psychiatry147, 1018-1020.
6.
Wender, P.H., Reimherr, F.W. , & Wood, D.R. ( 1981 ). Attention deficit disorder ("minimal brain dysfunction") in adults: A replication study of diagnosis and drug treatment. Archives of General Psychiatry38, 449-456.
7.
Wender, P.H., Wood, D.R. , Reimherr, F.W., & Ward, M. (1983). An open trial of pargyline in the treatment of attention deficit disorder, residual type . Psychiatry Research9, 329-336.
Wood, D.R., Reimherr, F.W. , & Wender, P.H. ( 1983). The use of 1-deprenyl in the treatment of attention deficit disorder, residual type (ADD, RT). Psychopharmacological Bulletin19, 627-629.
10.
Wood, D.R., Reimherr, F.W. , & Wender, P.H. ( 1985). The treatment of attention deficit disorder with dl-phenylalanine . Psychiatry Research16, 21-26 (1985).
